产品名称：Human NKG2A Antibody (Monalizumab, Research Use)
产品编号：NBR-0257
针对靶点：NKG2A
抗体药商品名：Monalizumab
抗体药描述：Monalizumab (IPH2201) is a potentially first-in-class immune checkpoint inhibitor targeting NKG2A receptors expressed on tumor infiltrating cytotoxic CD8+ T cells and NK cells. 产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

  Gene Name: NKG2A
Synonyms: CD159a; NKG2; NKG2-A; NKG2-B
Target Description: Immune inhibitory receptor involved in self-nonself discrimination. In complex with KLRD1 on cytotoxic and regulatory lymphocyte subsets, recognizes non-classical major histocompatibility (MHC) class Ib molecule HLA-E loaded with self-peptides derived from the signal sequence of classical MHC class Ia molecules. 
Ensembl: ENSG00000134545 
Uniprot: P26715